BFC Planning’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
BFC Planning's XENE Position: Q3 2026 in Review
BFC Planning increased its Xenon Pharmaceuticals (XENE) stake by 37% in Q3 2026, buying an estimated $1.31K and bringing the position to 81 shares worth $3.01K. The position accounts for ﹤0.01% of the portfolio, ranked #2883.
BFC Planning first reported a position in XENE in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.56K in Q2 2026. 196 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- BFC Planning held 81 shares of Xenon Pharmaceuticals worth $3.01K as of Q3 2026.
- BFC Planning bought 22 Xenon Pharmaceuticals shares in Q3 2026, an estimated $1.31K.
- Xenon Pharmaceuticals made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #2883 holding.
- BFC Planning first reported a position in Xenon Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Xenon Pharmaceuticals position peaked at $3.56K in Q2 2026.
- 196 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.